Literature DB >> 33455953

Enhancing islet transplantation using a biocompatible collagen-PDMS bioscaffold enriched with dexamethasone-microplates.

Rosita Primavera1,2,3, Mehdi Razavi1,4,3, Bhavesh D Kevadiya1, Jing Wang1, Akshara Vykunta1, Daniele Di Mascolo2, Paolo Decuzzi2,5, Avnesh S Thakor1,5.   

Abstract

Islet transplantation is a promising approach to enable type 1 diabetic patients to attain glycemic control independent of insulin injections. However, up to 60% of islets are lost immediately following transplantation. To improve this outcome, islets can be transplanted within bioscaffolds, however, synthetic bioscaffolds induce an intense inflammatory reaction which can have detrimental effects on islet function and survival. In the present study, we first improved the biocompatibility of polydimethylsiloxane (PDMS) bioscaffolds by coating them with collagen. To reduce the inflammatory response to PDMS bioscaffolds, we then enriched the bioscaffolds with dexamethasone-loaded microplates (DEX-μScaffolds). These DEX-microplates have the ability to release DEX in a sustained manner over 7 weeks within a therapeutic range that does not affect the glucose responsiveness of the islets but which minimizes inflammation in the surrounding microenvironment. The bioscaffold showed excellent mechanical properties that enabled it to resist pore collapse thereby helping to facilitate islet seeding and its handling for implantation, and subsequent engraftment, within the epididymal fat pad (EFP). Following the transplantation of islets into the EFP of diabetic mice using DEX-μScaffolds there was a return in basal blood glucose to normal values by day 4, with normoglycemia maintained for 30 d. Furthermore, these animals demonstrated a normal dynamic response to glucose challenges with histological evidence showing reduced pro-inflammatory cytokines and fibrotic tissue surrounding DEX-μScaffolds at the transplantation site. In contrast, diabetic animals transplanted with either islets alone or islets in bioscaffolds without DEX microplates were not able to regain glycemic control during basal conditions with overall poor islet function. Taken together, our data show that coating PDMS bioscaffolds with collagen, and enriching them with DEX-microplates, significantly prolongs and enhances islet function and survival.
© 2021 IOP Publishing Ltd.

Entities:  

Keywords:  bioscaffold; dexamethasone; diabetes; inflammation; islet transplantation; microplates

Mesh:

Substances:

Year:  2021        PMID: 33455953      PMCID: PMC8530023          DOI: 10.1088/1758-5090/abdcac

Source DB:  PubMed          Journal:  Biofabrication        ISSN: 1758-5082            Impact factor:   9.954


  72 in total

1.  Collagen IV-modified scaffolds improve islet survival and function and reduce time to euglycemia.

Authors:  Woon Teck Yap; David M Salvay; Michael A Silliman; Xiaomin Zhang; Zachary G Bannon; Dixon B Kaufman; William L Lowe; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2013-06-27       Impact factor: 3.845

Review 2.  Immune responses to implants - a review of the implications for the design of immunomodulatory biomaterials.

Authors:  Sandra Franz; Stefan Rammelt; Dieter Scharnweber; Jan C Simon
Journal:  Biomaterials       Date:  2011-06-28       Impact factor: 12.479

Review 3.  Extracellular Matrix Bioscaffolds as Immunomodulatory Biomaterials<sup/>.

Authors:  Jenna L Dziki; Luai Huleihel; Michelle E Scarritt; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2017-05-19       Impact factor: 3.845

4.  The effect of silicone hydrogel contact lens composition on dexamethasone release.

Authors:  Giuliano Guidi; Timothy C Hughes; Marlena Whinton; Michael A Brook; Heather Sheardown
Journal:  J Biomater Appl       Date:  2014-02-20       Impact factor: 2.646

5.  Proangiogenic hydrogels within macroporous scaffolds enhance islet engraftment in an extrahepatic site.

Authors:  Ann-Christina Brady; Mikaël M Martino; Eileen Pedraza; Steve Sukert; Antonello Pileggi; Camillo Ricordi; Jeffrey A Hubbell; Cherie L Stabler
Journal:  Tissue Eng Part A       Date:  2013-08-09       Impact factor: 3.845

6.  Controlled Release of Dexamethasone from Organosilicone Constructs for Local Modulation of Inflammation in Islet Transplantation.

Authors:  Jessica D Weaver; Yun Song; Ethan Y Yang; Camillo Ricordi; Antonello Pileggi; Peter Buchwald; Cherie L Stabler
Journal:  Tissue Eng Part A       Date:  2015-07-10       Impact factor: 3.845

7.  Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets.

Authors:  C Lambillotte; P Gilon; J C Henquin
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

8.  Five-year follow-up after clinical islet transplantation.

Authors:  Edmond A Ryan; Breay W Paty; Peter A Senior; David Bigam; Eman Alfadhli; Norman M Kneteman; Jonathan R T Lakey; A M James Shapiro
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

Review 9.  Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?

Authors:  S J Cleland; B M Fisher; H M Colhoun; N Sattar; J R Petrie
Journal:  Diabetologia       Date:  2013-04-24       Impact factor: 10.122

10.  Enhanced function of immuno-isolated islets in diabetes therapy by co-encapsulation with an anti-inflammatory drug.

Authors:  Tram T Dang; Anh V Thai; Joshua Cohen; Jeremy E Slosberg; Karolina Siniakowicz; Joshua C Doloff; Minglin Ma; Jennifer Hollister-Lock; Katherine M Tang; Zhen Gu; Hao Cheng; Gordon C Weir; Robert Langer; Daniel G Anderson
Journal:  Biomaterials       Date:  2013-05-07       Impact factor: 12.479

View more
  2 in total

1.  Insulin Granule-Loaded MicroPlates for Modulating Blood Glucose Levels in Type-1 Diabetes.

Authors:  Rosita Primavera; Elena Bellotti; Daniele Di Mascolo; Martina Di Francesco; Jing Wang; Bhavesh D Kevadiya; Angelo De Pascale; Avnesh S Thakor; Paolo Decuzzi
Journal:  ACS Appl Mater Interfaces       Date:  2021-11-09       Impact factor: 9.229

2.  Localized drug delivery graphene bioscaffolds for cotransplantation of islets and mesenchymal stem cells.

Authors:  Mehdi Razavi; Jing Wang; Avnesh S Thakor
Journal:  Sci Adv       Date:  2021-11-17       Impact factor: 14.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.